Key result
Hydrogen sulfide promotes cardioprotection against myocardial ischemia via anti-apoptotic, anti-inflammatory, and antioxidant pathways.
Answers are grounded in this paper and cite their sources.
Reveals cardioprotective properties of hydrogen sulfide against myocardial ischaemia, highlighting its emerging potential as a cardiovascular therapeutic.
H2S (hydrogen sulfide), viewed with dread for more than 300 years, is rapidly becoming a ubiquitously present and physiologically relevant signalling molecule. Knowledge of the production and metabolism of H2S has spurred interest in delineating its functions both in physiology and pathophysiology of disease. Although its role in blood pressure regulation and interaction with NO is controversial, H2S, through its anti-apoptotic, anti-inflammatory and antioxidant effects, has demonstrated significant cardioprotection. As a result, a number of sulfide-donor drugs, including garlic-derived polysulfides, are currently being designed and investigated for the treatment of cardiovascular conditions, specifically myocardial ischaemic disease. However, huge gaps remain in our knowledge about this gasotransmitter. Only by additional studies will we understand more about the role of this intriguing molecule in the treatment of cardiovascular disease.
No takes yet. Share an insight, caveat, or question.
Lavu et al. (2010) conducted a review in Cardiovascular disease, specifically myocardial ischaemic disease. Hydrogen sulfide (H2S) and sulfide-donor drugs (including garlic-derived polysulfides) was evaluated on Cardioprotection. Hydrogen sulfide demonstrates cardioprotection via anti-apoptotic, anti-inflammatory, and antioxidant effects, prompting investigation of sulfide-donor drugs for myocardial ischaemic disease.
Synapse has enriched 10 related papers. Consider them for comparative context: